Echo Therapeutics, Inc. Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31)
Echo Therapeutics, Inc. had Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) of $3.90 million as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure · last filed 2013-05-10
- 2013-03-31: Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) $3.90M.
- 2012-12-31: Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) $5.58M.
- 2012-09-30: Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) $6.77M.
- 2012-06-30: Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) $393.00K.
| Period end | Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) |
|---|---|
| 2013-03-31 | $3.90M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $5.58M 10-Q · filed 2013-05-10 |
| 2012-09-30 | $6.77M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $393.00K 10-Q · filed 2012-08-09 |
| 2011-12-31 | $1.03M 10-K · filed 2013-03-18 |